Moderna has hired a former FBI agent to compile internal company reports about “high-risk” celebrities — including tennis ...

The resizing, which resulted in $1.4 billion in charges during the third quarter, aims to make the company's Covid vaccine profitable in 2024 and beyond, Moderna CEO Stéphane Bancel said in a ...

CLAY TRAVIS (HOST): The stock prices of Pfizer and Moderna have tanked partly as a result of these COVID shot failures and I believe, if we had not given and by we I mean our government ...

Moderna booked $3.1 billion in charges tied to excess Covid-19 vaccine doses and other costs last quarter. (fred tanneau/Agence France-Presse/Getty Images) Moderna (MRNA) swung to a loss and ...

Moderna Inc (NASDAQ: MRNA) shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent ...

Nov 2 (Reuters) - Moderna MRNA.O on Thursday said it expected 2023 revenue of at least $6 billion, tempering its forecast to reflect weaker demand for COVID-19 vaccines, but added it would return ...

When vaccines go bad, so does your bottom line. Moderna posted a quarterly loss of $3.63 billion on Thursday, half of which was accounted for by unused Covid ... a 36% increase from the same ...

Nov 2 (Reuters) - Moderna (MRNA.O) on Thursday said its 2023 sales would only hit the low end of its $6 billion to $8 billion forecast, reflecting weaker demand for COVID-19 vaccines, and its ...

News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...

(AP pic) CAMBRIDGE: Moderna said today that its 2023 sales would only hit the low end of its previous forecast, reflecting weaker demand for Covid-19 vaccines, and its shares plummeted over 16% in ...

Anti-vaccine advocates have recently made allegations against the Pfizer COVID-19 vaccine in hopes that the charges may hurt the drug manufacturer. "Either they admit that they knew about the ...